PROTEOfectene® AB complexates antibodies noncovalently by means of electrostatic and hydrophobic interactions, forming a proteoplex which is taken up by cells through endocytosis and finally releases the antibodies in the cell cytosol while retaining full functionality and maintaining epitopic binding affinity. PROTEOfectene® AB can be used to introduce mono- and polyclonal antibodies of all isotypes.
E020-0.25
PROTEOfectene® enables proteins to be introduced directly into mammalian cells without the need for prior gene expression.
E010-0.1
PROTEOfectene® enables proteins to be introduced directly into mammalian cells without the need for prior gene expression.
E010-0.25
PROTEOfectene® AB complexates antibodies noncovalently by means of electrostatic and hydrophobic interactions, forming a proteoplex which is taken up by cells through endocytosis and finally releases the antibodies in the cell cytosol while retaining full functionality and maintaining epitopic binding affinity. PROTEOfectene® AB can be used to introduce mono- and polyclonal antibodies of all isotypes.
E020-0.1